XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 43.5

Change

+0.07 (+0.16)%

Market Cap

CAD 0.58B

Volume

2.85K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-14 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.61 (+0.42%)

CAD 21.09B
ZSP:CA BMO S&P 500

+0.34 (+0.38%)

CAD 17.10B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.04 (+0.06%)

CAD 11.46B
VUN:CA Vanguard US Total Market

+0.33 (+0.30%)

CAD 10.87B
XUS:CA iShares Core S&P 500 Index ETF

+0.19 (+0.37%)

CAD 8.70B
HXS:CA Global X S&P 500 Corporate Cla..

+0.28 (+0.33%)

CAD 4.34B
VSP:CA Vanguard S&P 500 CAD hedged

+0.10 (+0.11%)

CAD 4.04B
QUU:CA Mackenzie US Large Cap Equity ..

-0.63 (-0.26%)

CAD 3.60B
XUU:CA iShares Core S&P US Total Mark..

+0.25 (+0.41%)

CAD 3.34B
ZUE:CA BMO S&P 500 (CAD Hedged)

+0.17 (+0.21%)

CAD 3.23B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.14% 16% F 26% F
Dividend Return 0.20% 17% F 5% F
Total Return -2.94% 14% F 25% F
Trailing 12 Months  
Capital Gain 13.31% 78% C+ 74% C
Dividend Return 1.00% 27% F 17% F
Total Return 14.31% 78% C+ 71% C-
Trailing 5 Years  
Capital Gain 98.45% 72% C 77% C+
Dividend Return 7.24% 21% F 10% F
Total Return 105.69% 70% C- 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.18% 76% C+ 81% B-
Dividend Return 15.12% 74% C 78% C+
Total Return 0.94% 35% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 15.02% 38% F 53% F
Risk Adjusted Return 100.67% 60% D- 93% A
Market Capitalization 0.58B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.